Skip to Content

The Future is Now: Patient-Centered Trials, Telemedicine, & Moving into the Home

Lessons Learned from a Virtual Town Hall held on April 17, 2020

There’s no denying that the COVID-19 pandemic has spurred tremendous innovation across our industry.

Even more impressive is the pace at which we’ve been able to implement technology solutions that can facilitate continued progress in our critical activities and trials. Most importantly, the expansion of telemedicine and virtual solutions is enabling us to meet our patients’ needs while also maintaining patient safety, study integrity, and data quality.

During Halloran’s 5th Virtual Town Hall, expert panelists discussed the telemedicine technology landscape before the COVID-19 outbreak, considerations around vetting and implementing these solutions during the pandemic, and the future of virtual visit technology as shaped by the current environment.

Telemedicine Pre-COVID

What did the technology landscape look like in clinical trial conduct before COVID-19?

Telemedicine During COVID

What is the argument for the use of telemedicine/virtual visit technology?

What should sponsors consider when planning the use of a telemedicine or virtual visit solution?

What should sponsors consider when selecting a telemedicine / virtual visit vendor or methodology?

What technology is in-flight currently?

Telemedicine Post-COVID

How will we ensure that the innovation spurred by COVID-19 endures into the future?

While COVID-19 is devastating to our industry in many ways, we can choose to answer the call-to-arms that this situation has presented: we must collaborate in order to make true change in our industry. The opportunity for disruptive innovation is at our doorstep, and we have all the tools we need to build real change in the way we design and conduct clinical trials.

We must work together to realize the potential that we have to create enduring solutions that will better meet the needs of the patients we serve.

Please reach out to us if we can help in any way or would like to be included in any of our upcoming town halls.


Laurie Halloran, CEO |
Greg Dombal, President & COO |
Paola Murphy, Chief Client Officer |
Katie McCarthy, Chief Development Officer |
Sheila Gwizdak, VP, Quality |
Kim Raymer, VP, Regulatory Affairs |
Jason Milovanovic, VP, Clinical Development |